Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Astrid Strelow
Introduction
Astrid Strelow is a notable inventor based in Redwood City, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. Her work has the potential to impact cancer treatment and therapeutic methods.
Latest Patents
Astrid Strelow holds one patent for her invention titled "PRO115 antibody compositions and methods of use." This invention provides isolated anti-Pro115 antibodies that specifically bind to Pro115. The patent also encompasses compositions that include an anti-Pro115 antibody and a carrier, which can be packaged in an article of manufacture or a kit. Additionally, the invention includes an isolated nucleic acid encoding an anti-Pro115 antibody, as well as an expression vector containing the isolated nucleic acid. The invention further details methods for producing the anti-Pro115 antibodies and outlines techniques for targeting Pro115-expressing cancer cells. This includes methods for killing these cancer cells and treating Pro115-expressing cancers in mammals through the administration of therapeutically effective amounts of the anti-Pro115 antibody.
Career Highlights
Astrid Strelow is currently associated with Diadexus, Inc., where she continues to advance her research and development efforts. Her innovative work in antibody technology has positioned her as a key figure in the biotechnology sector.
Collaborations
Some of her notable coworkers include Gundo Diedrich and Paul Levi Miller. Their collaborative efforts contribute to the ongoing research and development initiatives at Diadexus, Inc.
Conclusion
Astrid Strelow's contributions to the field of biotechnology, particularly through her patent on anti-Pro115 antibodies, highlight her role as an influential inventor. Her work has the potential to significantly impact cancer treatment methodologies.